Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Witkin

Showing results (191-200 of 321) with videos related to

Pageof 33
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Pharmacological analysis of the scratching produced by dopamine D2 agonists in squirrel monkeysR Pellón, P Flores, K Alling, et al.
Molecular & General Genetics : MGG|January 1, 1982
Constitutive expression of SOS functions and modulation of mutagenesis resulting from resolution of genetic instability at or near the recA locus of Escherichia coliE M Witkin, J O McCall, M R Volkert, et al.
Synapse (New York, N.Y.)|September 20, 2024
High Impact AMPAkines Induce a Gq-Protein Coupled Endoplasmic Calcium Release in Cortical Neurons: A Possible Mechanism for Explaining the Toxicity of High Impact AMPAkinesDaniel P Radin, Sheng Zhong, Rok Cerne, et al.
Neuroscience Letters|May 25, 2005
Genetic deletion of the norepinephrine transporter decreases vulnerability to seizuresRafal M Kaminski, Toni S Shippenberg, Jeffrey M Witkin, et al.
Epilepsy Research|May 9, 2007
Constitutive deletion of the serotonin-7 (5-HT(7)) receptor decreases electrical and chemical seizure thresholdsJeffrey M Witkin, Melvyn Baez, Jianliang Yu, et al.
Pharmacology, Biochemistry, and Behavior|June 17, 2019
A medium throughput rodent model of relapse from addiction with behavioral and pharmacological specificityWilliam J A Eiler, Scott D Gleason, Jodi L Smith, et al.
Behavioural Pharmacology|August 13, 2011
Multiple dopamine receptors mediate the discriminative stimulus effects of dihydrexidine in ratsScott D Gleason, Tinggui Yin, Sheila P Little, et al.
Neuropharmacology|April 13, 2000
Acute and chronic effects of the synthetic neuroactive steroid, ganaxolone, against the convulsive and lethal effects of pentylenetetrazol in seizure-kindled mice: comparison with diazepam and valproateM Gasior, J T Ungard, M Beekman, et al.
European Journal of Pharmacology|August 9, 2025
Low-impact ampakine CX717 exhibits promising therapeutic profile in adults with ADHD - A phase 2A clinical trialDaniel P Radin, Rok Cerne, Jodi L Smith, et al.
Journal of Psychiatric Research|April 17, 2025
Antipsychotic-like pharmacological profile of the low impact ampakine CX691 (farampator): Implications for the use of low impact ampakines in the treatment of schizophreniaDaniel P Radin, Rok Cerne, Jodi L Smith, et al.
Pageof 33

Showing results (191-200 of 321) with videos related to

Sort By:
Pageof 33
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1995
Pharmacological analysis of the scratching produced by dopamine D2 agonists in squirrel monkeysR Pellón, P Flores, K Alling, et al.
Molecular & General Genetics : MGG|January 1, 1982
Constitutive expression of SOS functions and modulation of mutagenesis resulting from resolution of genetic instability at or near the recA locus of Escherichia coliE M Witkin, J O McCall, M R Volkert, et al.
Synapse (New York, N.Y.)|September 20, 2024
High Impact AMPAkines Induce a Gq-Protein Coupled Endoplasmic Calcium Release in Cortical Neurons: A Possible Mechanism for Explaining the Toxicity of High Impact AMPAkinesDaniel P Radin, Sheng Zhong, Rok Cerne, et al.
Neuroscience Letters|May 25, 2005
Genetic deletion of the norepinephrine transporter decreases vulnerability to seizuresRafal M Kaminski, Toni S Shippenberg, Jeffrey M Witkin, et al.
Epilepsy Research|May 9, 2007
Constitutive deletion of the serotonin-7 (5-HT(7)) receptor decreases electrical and chemical seizure thresholdsJeffrey M Witkin, Melvyn Baez, Jianliang Yu, et al.
Pharmacology, Biochemistry, and Behavior|June 17, 2019
A medium throughput rodent model of relapse from addiction with behavioral and pharmacological specificityWilliam J A Eiler, Scott D Gleason, Jodi L Smith, et al.
Behavioural Pharmacology|August 13, 2011
Multiple dopamine receptors mediate the discriminative stimulus effects of dihydrexidine in ratsScott D Gleason, Tinggui Yin, Sheila P Little, et al.
Neuropharmacology|April 13, 2000
Acute and chronic effects of the synthetic neuroactive steroid, ganaxolone, against the convulsive and lethal effects of pentylenetetrazol in seizure-kindled mice: comparison with diazepam and valproateM Gasior, J T Ungard, M Beekman, et al.
European Journal of Pharmacology|August 9, 2025
Low-impact ampakine CX717 exhibits promising therapeutic profile in adults with ADHD - A phase 2A clinical trialDaniel P Radin, Rok Cerne, Jodi L Smith, et al.
Journal of Psychiatric Research|April 17, 2025
Antipsychotic-like pharmacological profile of the low impact ampakine CX691 (farampator): Implications for the use of low impact ampakines in the treatment of schizophreniaDaniel P Radin, Rok Cerne, Jodi L Smith, et al.
Pageof 33